Spectral MD, Inc.

Spectral MD (trading as Spectral AI) is a Dallas-based medical device company specializing in predictive wound healing diagnostics. The company's flagship product, the DeepView® Wound Imaging System, combines multispectral imaging technology with proprietary artificial intelligence algorithms to provide rapid, noninvasive wound healing assessments. The system differentiates between damaged and healthy tissue, delivering immediate binary healing predictions and detailed healing maps on Day One of assessment. DeepView supports clinical decision-making across multiple wound types including burns, diabetic foot ulcers, and acute/chronic wounds. The technology has received FDA Breakthrough Device Designation. The company is publicly traded on NASDAQ (ticker: MDAI) and holds 12 U.S. patents and 14 foreign patents related to its multispectral imaging and predictive AI platform.